TCT-592 Lower Five Year Event Rates In The Genous Endothelial Progenitor Cell Capturing Stent Compared With A Drug Eluting Stent In De-novo Coronary Artery Lesions With A High-risk Of Restenosis; A Randomized Controlled Trial

Coronary Artery ◽

Progenitor Cell ◽

De Novo ◽

Controlled Trial ◽

Drug Eluting Stent ◽

Coronary Artery Lesions ◽

Randomized Controlled ◽

Drug Eluting ◽

Event Rates

Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery Lesions: The REALITY Trial: A Randomized Controlled Trial

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70218-9 ◽

2007 ◽

Vol 2007 ◽

pp. 344-347

Author(s):

W.H. Frishman

Keyword(s):

Coronary Artery ◽

De Novo ◽

Controlled Trial ◽

Coronary Artery Lesions ◽

Randomized Controlled

Erratum to: Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial

Trials ◽

10.1186/s13063-017-1793-y ◽

2017 ◽

Vol 18 (1) ◽

Author(s):

Sang-Don Park ◽

Chang-Hwan Yoon ◽

Il-Young Oh ◽

Jung-Won Suh ◽

Young-Suk Cho ◽

...

Keyword(s):

De Novo ◽

Controlled Trial ◽

Bare Metal Stent ◽

Drug Eluting Stent ◽

Bare Metal ◽

Metal Stent ◽

Randomized Controlled ◽

Drug Eluting ◽

Drug Eluting Balloon

Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial

Trials ◽

10.1186/1745-6215-14-38 ◽

2013 ◽

Vol 14 (1) ◽

Cited By ~ 2

Author(s):

Sang-Don Park ◽

Chang-Hwan Yoon ◽

Il-Young Oh ◽

Jung-Won Suh ◽

Young-Suk Cho ◽

...

Keyword(s):

De Novo ◽

Controlled Trial ◽

Bare Metal Stent ◽

Drug Eluting Stent ◽

Bare Metal ◽

Metal Stent ◽

Randomized Controlled ◽

Drug Eluting ◽

Drug Eluting Balloon

TCT-312 4-year Clinical Results of a Randomized trial Evaluating the Absorb Bioresorbable Vascular Scaffold vs. Metallic Drug-eluting Stent in de novo Native Coronary Artery Lesions: Data from the ABSORB Japan Trial

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2018.08.1453 ◽

2018 ◽

Vol 72 (13) ◽

pp. B128-B129

Author(s):

Kengo Tanabe ◽

Ken Kozuma ◽

Takeshi Kimura

Keyword(s):

Coronary Artery ◽

Randomized Trial ◽

De Novo ◽

Clinical Results ◽

Drug Eluting Stent ◽

Coronary Artery Lesions ◽

Bioresorbable Vascular Scaffold ◽

Native Coronary Artery ◽

Vascular Scaffold ◽

TCT-165 5-Year Clinical Results of a Randomized Trial Evaluating the Absorb Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in De Novo Native Coronary Artery Lesions: Data From the ABSORB Japan Trial

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2019.08.220 ◽

2019 ◽

Vol 74 (13) ◽

pp. B164

Author(s):

Ken Kozuma ◽

Takeshi Kimura ◽

Kengo Tanabe

Keyword(s):

Coronary Artery ◽

Randomized Trial ◽

De Novo ◽

Clinical Results ◽

Drug Eluting Stent ◽

Coronary Artery Lesions ◽

Bioresorbable Vascular Scaffold ◽

Native Coronary Artery ◽

Vascular Scaffold ◽

Drug-coated Balloon Versus Drug-eluting Stent in the Treatment of Coronary Artery Lesions in STEMI Patients in De Novo Coronary Lesions

Case Medical Research ◽

10.31525/ct1-nct04072081 ◽

2019 ◽

Author(s):

Keyword(s):

Coronary Artery ◽

De Novo ◽

Drug Eluting Stent ◽

Coronary Artery Lesions ◽

Drug Eluting ◽

Coronary Lesions ◽

Drug Coated Balloon

Faculty of 1000 evaluation for ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717964511.793474479 ◽

2013 ◽

Author(s):

Gregor Theilmeier ◽

Jan Larmann

Keyword(s):

De Novo ◽

Controlled Trial ◽

Coronary Artery Lesions ◽

Bioresorbable Vascular Scaffold ◽

Native Coronary Artery ◽

Randomized Controlled ◽

Stent System ◽

Vascular Scaffold ◽

And Performance

Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial

Trials ◽

10.1186/1745-6215-14-56 ◽

2013 ◽

Vol 14 (1) ◽

pp. 56 ◽

Cited By ~ 11

Author(s):

Gérard Helft ◽

Claude Le Feuvre ◽

Jean Louis Georges ◽

Didier Carrie ◽

Florence Leclercq ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Study Protocol ◽

Dual Antiplatelet Therapy ◽

Controlled Trial ◽

Drug Eluting Stent ◽

Efficacy And Safety ◽

Randomized Controlled ◽

XLIMus drug eluting stent: A randomIzed controlled Trial to assess endothelialization. The XLIMIT trial

IJC Heart & Vasculature ◽

10.1016/j.ijcha.2019.100363 ◽

2019 ◽

Vol 23 ◽

pp. 100363

Author(s):

Luca Testa ◽

Gaetano Pero ◽

Mario Bollati ◽

Matteo Casenghi ◽

Antonio Popolo Rubbio ◽

...

Keyword(s):

Controlled Trial ◽

Drug Eluting Stent ◽

Randomized Controlled ◽

INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial

Trials ◽

10.1186/1745-6215-13-55 ◽

2012 ◽

Vol 13 (1) ◽

Cited By ~ 4

Author(s):

Francesco Burzotta ◽

Marta Francesca Brancati ◽

Carlo Trani ◽

Italo Porto ◽

Antonella Tommasino ◽

...

Keyword(s):

De Novo ◽

Controlled Trial ◽

Bare Metal Stent ◽

Bare Metal ◽

Metal Stent ◽

Randomized Controlled ◽

Drug Eluting ◽

Coronary Lesions ◽

Drug Eluting Balloon